Clinical Trials Directory

Trials / Completed

CompletedNCT06733818

Physical Function From the Perspective of Active Ageing

The Evaluation of the Levels of Physical Function in Older Adults From the Perspective of Active Ageing

Status
Completed
Phase
Study type
Observational
Enrollment
455 (actual)
Sponsor
Suleyman Demirel University · Academic / Other
Sex
All
Age
55 Years – 95 Years
Healthy volunteers

Summary

The aim of this study is to evaluate physical function from the perspective of active aging as well as to determine the relationship between physical activity and physical performance in the context of active aging. This cross-sectional study was conducted with the participation of 215 (47.3%) males and 230 (52.7%) females, with a mean age of 69.09±8.59 years. Functional assessment of physical performance (Alusti), Physical Activity Scale for Elderly (PASE), and University of Jyvaskyla Active Ageing Scale (UJACAS) were employed to assess physical function and active aging levels of the elderly.

Conditions

Interventions

TypeNameDescription
OTHERFunctional assessment of physical performanceFunctional assessment of physical performance was performed with the Alusti test. This 10-question test was developed to assess physical performance in the geriatric population 13 and has been validated in Turkish 14. This test evaluates limb range of motion and muscle strength, ability to move from supine to sitting position, sitting balance, ability to stand up from sitting position, standing, walking, walking distance, ability to stand on tandem and single leg with eyes closed. The results of this test, which is scored out of 100, indicate the level of activity. 0-30, interpreted as totally dependent; 31-40, highly dependent; 41-50, moderately dependent; 51-60, slightly dependent; 61-75, good activity; 76-90, very good activity; and 91-100, excellent activity.

Timeline

Start date
2024-01-04
Primary completion
2024-06-28
Completion
2024-09-10
First posted
2024-12-13
Last updated
2024-12-13

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06733818. Inclusion in this directory is not an endorsement.